title: Essential hypertension and beta2-adrenergic receptor gene: linkage and association analysis.
abstract: A region on human chromosome 5 (5q31.1-qter) contains several genes that encode important blood pressure regulators and thus is a good candidate for analysis of linkage and association with hypertension. We recruited 638 individuals from 212 Polish pedigrees with clustering of essential hypertension. These subjects were genotyped for 11 microsatellite markers that span this region to test for linkage to essential hypertension and systolic and diastolic blood pressures. The segment of this region of approximately 7 cM delineated by D5S1480 and D5S500 markers was linked to blood pressures in multipoint analysis. In 2-point analysis, D5S1480--the marker in close proximity to beta2-adrenergic receptor gene--reached the maximal linkage to essential hypertension and adjusted systolic and diastolic blood pressures, implicating this gene as a positional candidate for further association studies. Arg16Gly, Gln27Glu, and Thr164Ile--3 functional single nucleotide polymorphisms within the beta2-adrenergic receptor gene--were tested for association with essential hypertension. None of these polymorphisms showed a significant association with essential hypertension, separately or in the haplotype analysis. This study provided evidence of linkage of 5q31.1-5qter region to essential hypertension in the European population. Moreover, it implicated the chromosomal segment in close proximity to D5S1480 and D5S500. The detailed analysis of 3 single nucleotide polymorphisms does not support the role of the beta2-adrenergic receptor gene as a major causative gene for the detected linkage.
authors.affiliation: British Heart Foundation Blood Pressure Group, Department of Medicine and Therapeutics, University of Glasgow, Glasgow, United Kingdom.
authors.forename: Maciej
authors.initials: M
authors.lastname: Tomaszewski
authors.forename: Nick J R
authors.initials: NJ
authors.lastname: Brain
authors.forename: Fadi J
authors.initials: FJ
authors.lastname: Charchar
authors.forename: William Y S
authors.initials: WY
authors.lastname: Wang
authors.forename: Beata
authors.initials: B
authors.lastname: Lacka
authors.forename: Sandosh
authors.initials: S
authors.lastname: Padmanabahn
authors.forename: James S
authors.initials: JS
authors.lastname: Clark
authors.forename: Niall H
authors.initials: NH
authors.lastname: Anderson
authors.forename: Helen V
authors.initials: HV
authors.lastname: Edwards
authors.forename: Ewa
authors.initials: E
authors.lastname: Zukowska-Szczechowska
authors.forename: Wladyslaw
authors.initials: W
authors.lastname: Grzeszczak
authors.forename: Anna F
authors.initials: AF
authors.lastname: Dominiczak
mesh_terms: D000328:Adult; D001794:Blood Pressure / Q000235:genetics; D002874:Chromosome Mapping; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics; D005260:Female; D008040:Genetic Linkage; D020022:Genetic Predisposition to Disease; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D018343:Receptors, Adrenergic, beta-2 / Q000235:genetics*
chemical_list: D018343:Receptors, Adrenergic, beta-2